Dong-A Pharmaceutical

Dong-A Pharmaceutical, established in 1932, stands as a cornerstone of the South Korean healthcare sector. As a primary entity within the Dong-A Socio Group, the organization integrates pharmaceutical manufacturing with digital healthcare, consumer products, and specialized logistics services. The company maintains a robust commitment to enhancing human health through innovation and consumer-oriented management strategies. By leveraging its extensive history, Dong-A Pharmaceutical provides a diverse portfolio of medical solutions, health functional foods, and integrated IT services designed to meet the evolving needs of healthcare providers and individual consumers across the Asia-Pacific region.

The company operates with a workforce of 1,000-5,000 employees, maintaining a singular, centralized location in Seoul, South Korea. This operational footprint supports its multifaceted business model, which spans pharmaceutical development, engineering, and logistics. Dong-A Pharmaceutical utilizes advanced technical infrastructure to ensure the delivery of high-quality medical products and services. Their business model is characterized by a focus on social responsibility and sustainable growth, ensuring that all operations align with international healthcare standards. The firm continues to invest in research and development to maintain its competitive edge in the pharmaceutical and healthcare industries.

With annual revenue reaching $466.4M, strategic management remains central to the firm's long-term success, with leadership overseeing complex operations across multiple sectors. Meet Dong-A Pharmaceutical's team to gain insights into the organizational structure and the professional expertise driving their current initiatives. The company’s focus on B2B and B2C markets allows it to maintain a significant presence in the regional healthcare landscape. By prioritizing innovation and maintaining a strong commitmentView more...